Volatility is common in stock markets and on Thursday it was the Northwest Biotherapeutics (OTC: NWBO) stock that experienced considerable volatility.
Although the stock had traded within a range over the course of the past few months, the stock was highly volatile on Thursday. It tanked by as high as 12.50% in the early period of the trading session and then recovered somewhat. However, it ended the day with a decline of as low as 6.5%.
The company announced yesterday that it had completed the development of the production capacity for the initial stage for its new plant at Swanston in the United Kingdom. It is a significant development for the company since it is going to a much larger plant than its current clean room facility located in London. The production capacity at this point is made up of as many as 2 manufacturing suites that span an area of as much as 4400 square feet.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life